Russell Investments Group
COGT icon

Russell Investments Group’s Cogent Biosciences COGT Stock Holding History

Russell Investments Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4M Buy
475,267
+100,399
+27% +$3.51M 0.02% 775
2026
Q1 		$14.4M Sell
374,868
-10,589
-3% -$391K 0.02% 758
2025
Q4 		$13.7M Buy
385,457
+264,512
+219% +$7.44M 0.01% 766
2025
Q3 		$1.74M Buy
120,945
+27,726
+30% +$328K ﹤0.01% 1930
2025
Q2 		$669K Buy
93,219
+63,376
+212% +$351K ﹤0.01% 2231
2025
Q1 		$179K Buy
29,843
+29,669
+17,051% +$233K ﹤0.01% 2626
2024
Q4 		$1.36K Hold
174
– – ﹤0.01% 3496
2024
Q3 		$1.88K Sell
174
-2,202
-93% -$21.4K ﹤0.01% 3388
2024
Q2 		$20K Sell
2,376
-7,638
-76% -$57.9K ﹤0.01% 2938
2024
Q1 		$67.3K Buy
10,014
+7,020
+234% +$43.4K ﹤0.01% 2622
2023
Q4 		$17.6K Buy
2,994
+345
+13% +$2.64K ﹤0.01% 2759
2023
Q3 		$25.8K Hold
2,649
– – ﹤0.01% 2840
2023
Q2 		$31.4K Sell
2,649
-4,000
-60% -$45.9K ﹤0.01% 2779
2023
Q1 		$71.7K Buy
+6,649
New +$85K ﹤0.01% 2653
2019
Q4 		– Sell
-1,229
Closed -$7K – 3095
2019
Q3 		$7K Hold
1,229
– – ﹤0.01% 2985
2019
Q2 		$13K Sell
1,229
-374
-23% -$4.98K ﹤0.01% 2808
2019
Q1 		$28K Buy
+1,603
New +$27.4K ﹤0.01% 2859

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Russell Investments Group's COGT Position: Q2 2026 in Review

Russell Investments Group increased its Cogent Biosciences (COGT) stake by 27% in Q2 2026, buying an estimated $3.51M and bringing the position to 475,267 shares worth $18.4M. The position accounts for 0.02% of the portfolio, ranked #775.

Russell Investments Group first reported a position in COGT in Q1 2019 and has held it in 17 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Russell Investments Group held 475,267 shares of Cogent Biosciences worth $18.4M as of Q2 2026.
  • Russell Investments Group bought 100,399 Cogent Biosciences shares in Q2 2026, an estimated $3.51M.
  • Cogent Biosciences made up 0.02% of Russell Investments Group's portfolio in Q2 2026, its #775 holding.
  • Russell Investments Group first reported a position in Cogent Biosciences in Q1 2019 and has held it in 17 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.